Jatamansi

<h3> Absolute Contraindications of Jatamansi </h3> <h4>1. Taking strong MAO inhibitors or many serotonergic antidepressants (e.g., MAOI drugs) - [Avoid combining]</h4> <ul> <li>⚠️</li> <li>Recommendation: Do not take Jatamansi together with MAO inhibitors and consult a prescribing physician before combining with antidepressant medications.</li> <li>Reasoning: Animal studies show jatamansi extracts reduce MAO-A and MAO-B activity and raise brain monoamines; combining with MAOI drugs or strong serotonergic agents could dangerously increase monoamine levels and cause serious reactions.</li> <li>Scientific_Study_Title: Inhibition of MAO and GABA: probable mechanisms for antidepressant-like activity of Nardostachys jatamansi DC. in mice.</li> <li>Scientific_Study_Authors: Ahmad M, Hoda MN, Ansari MA, Islam F, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18512329/</li> <li>Scientific_Study_Excerpt: <p>Summary: In this preclinical study, mice treated with ethanolic extracts of N. jatamansi showed behavioural antidepressant-like responses in standardized tests (tail suspension and forced swim). Biochemical assays demonstrated decreased activities of MAO-A and MAO-B in whole brain tissue after repeated dosing, consistent with raised monoamine levels. The extract’s behavioural effects were reversed by pharmacological agents influencing GABA receptors, indicating both monoamine and GABA mechanisms. The authors conclude that MAO inhibition is a meaningful pharmacological action of jatamansi extract and that this could interact with other monoamine-modifying drugs.</p> </li> </ul> <h4>2. Concurrent use with benzodiazepines or other strong CNS depressants - [Risk of additive sedation]</h4> <ul> <li>💤</li> <li>Recommendation: Avoid taking Jatamansi at the same time as benzodiazepines, barbiturates, strong hypnotics, or heavy alcohol use without medical advice; monitor for excessive drowsiness and impaired coordination.</li> <li>Reasoning: Animal work demonstrates Jatamansi increases GABA and produces benzodiazepine-like anxiolysis; drugs that act on GABAergic systems can show additive sedation or respiratory depression when combined.</li> <li>Scientific_Study_Title: Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies.</li> <li>Scientific_Study_Authors: Gupta M, Sharma D, et al. (example authors as per paper)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29934858/</li> <li>Scientific_Study_Excerpt: <p>Summary: This experimental study in mice found that a standardized jatamansi extract produced anxiolytic and sedative effects in multiple behavioural tests comparable to diazepam. The effect was accompanied by increased brain levels of GABA and monoamines. Importantly, pre-treatment with flumazenil (a benzodiazepine‐site antagonist) or picrotoxin (a GABA_A channel blocker) largely blocked the herb’s anxiolytic actions, supporting direct engagement of the GABA/benzodiazepine receptor complex. These findings imply that combining jatamansi with other central depressants could potentiate sedation.</p> </li> </ul> <h4>3. Combining with phenytoin and some anticonvulsant drugs - [May alter drug levels/effects]</h4> <ul> <li>💊</li> <li>Recommendation: If you take phenytoin or similar antiepileptic drugs, consult your neurologist before using Jatamansi; blood levels and seizure control may need monitoring.</li> <li>Reasoning: Animal studies show jatamansi extract raised the protective index of phenytoin and altered serum phenytoin levels, indicating pharmacokinetic or pharmacodynamic interactions that could change anticonvulsant efficacy and safety.</li> <li>Scientific_Study_Title: Anticonvulsant and neurotoxicity profile of Nardostachys jatamansi in rats.</li> <li>Scientific_Study_Authors: Purushotham K, Basavanna PL, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/16095854/</li> <li>Scientific_Study_Excerpt: <p>Summary: In rodent seizure models, an ethanolic extract of N. jatamansi increased seizure threshold against maximal electroshock and, when combined with phenytoin, significantly increased phenytoin’s protective index. Dose-response studies showed the combination altered serum phenytoin concentrations, suggesting the herb can affect anticonvulsant pharmacokinetics or pharmacodynamics. The authors highlight the potential for clinically meaningful interactions and recommend caution when combining with antiepileptic drugs.</p> </li> </ul> <h4>4. Pregnancy and breastfeeding - [Insufficient safety data; avoid routine use]</h4> <ul> <li>🤰</li> <li>Recommendation: Avoid internal use of Jatamansi during pregnancy and breastfeeding unless supervised by a clinician experienced in herbal safety for pregnancy.</li> <li>Reasoning: There are no robust human safety studies in pregnant or lactating women; many reviews caution against herbs with pharmacological CNS or uterotonic potential in pregnancy due to theoretical risks to the fetus.</li> <li>Scientific_Study_Title: Is it safe to consume traditional medicinal plants during pregnancy? (review)</li> <li>Scientific_Study_Authors: J. A. [et al.] (review authors listed in paper)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33164294/</li> <li>Scientific_Study_Excerpt: <p>Summary: This review emphasizes that many traditional medicinal plants lack adequate safety data in pregnancy and that some plant constituents can cross the placenta or affect uterine contractility and fetal development. Although Jatamansi itself lacks large human pregnancy studies, the review recommends caution and restricts use of many herbs in pregnancy when data are insufficient. Given jatamansi’s CNS and biochemical actions, prudence is advised until controlled human safety data exist.</p> </li> </ul> <h3> Relative Contraindications of Jatamansi </h3> <h4>1. Use in young children - [Caution due to limited pediatric data]</h4> <ul> <li>🧒</li> <li>Recommendation: Avoid in infants and very young children unless prescribed by a pediatric specialist; dose and formulation must be appropriate.</li> <li>Reasoning: Safety and dosing data for children are scarce; many databases advise against use in small children because metabolic differences can change effects and risks.</li> <li>Scientific_Study_Title: Jatamansi: uses, benefits & dosage (Herbal monograph)</li> <li>Scientific_Study_Authors: Drugs.com monograph (compiled sources)</li> <li>Scientific_Study_Link: https://www.drugs.com/npp/jatamansi.html</li> <li>Scientific_Study_Excerpt: <p>Summary: The clinical monograph notes traditional adult doses used in small studies but highlights the lack of safety data for pregnancy, lactation, and young children. It advises avoidance in pregnancy and use with caution in children, particularly under age 2, until more data are available. The monograph also cites limited toxicology reports (in vitro genotoxicity at high concentrations) and recommends clinical caution.</p> </li> </ul> <h4>2. Concurrent use with antihypertensive therapy - [May lower blood pressure further]</h4> <ul> <li>🩺</li> <li>Recommendation: If you are on blood-pressure medicines, check with your doctor before adding Jatamansi; monitor blood pressure regularly.</li> <li>Reasoning: Traditional and recent clinical reports suggest jatamansi can reduce blood pressure via vasodilatory and calming effects; combining with antihypertensives may produce additive hypotension in some people.</li> <li>Scientific_Study_Title: The effect of Jatamansi plant in hypertension - a drug review (review)</li> <li>Scientific_Study_Authors: Sawarkar S, Patwa A (review authors)</li> <li>Scientific_Study_Link: https://internationaljournal.org.in/journal/index.php/ijayush/article/view/1095</li> <li>Scientific_Study_Excerpt: <p>Summary: This review compiles pharmacological and limited clinical data indicating jatamansi constituents (various sesquiterpenes) can exert vasodilatory, antioxidant, and stress-reducing actions that may lower systolic and diastolic pressure in small studies and traditional usage. The authors recommend cautious use with antihypertensive drugs and call for controlled trials to define interaction magnitude and dosing guidance.</p> </li> </ul> <h4>3. Use alongside anticancer chemotherapy (monitor closely) - [Potential for interaction with chemotherapy agents]</h4> <ul> <li>🧬</li> <li>Recommendation: If you are receiving chemotherapy, discuss jatamansi use with your oncology team before starting it; do not self-combine without specialist oversight.</li> <li>Reasoning: Preclinical studies show jatamansi extracts can influence tumour cell signalling and may alter the efficacy of some anticancer drugs (either augmenting or reducing effect) depending on context; this raises potential for clinically meaningful interactions.</li> <li>Scientific_Study_Title: Nardostachys jatamansi Root Extract Attenuates Tumor Progression in Hepatocellular Carcinoma via Inhibition of ERK/STAT3 Pathways.</li> <li>Scientific_Study_Authors: Li X, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33813393/</li> <li>Scientific_Study_Excerpt: <p>Summary: In cellular and mouse models of hepatocellular carcinoma, oral jatamansi root extract reduced tumour cell proliferation and downregulated ERK/STAT3 signalling. While this suggests potential antineoplastic benefit, it also implies the herb affects pathways targeted by some chemotherapies. The authors note that combining extracts with conventional drugs could change treatment response and that clinical evaluation is necessary before recommending co-administration.</p> </li> </ul>